Built for the Complex Compliance Risks of Life Sciences

Life sciences compliance software is an umbrella term for solutions that help pharmaceutical, biotech, and medical device companies manage HCP/HCO engagement workflows, pre-approvals, compliance monitoring, and conflict-of-interest disclosures. Organizations use these solutions to support engagement management, grant and sponsorship approvals, transparency reporting, and third-party oversight across regions and engagement types.

HCP engagement software manages the full lifecycle of healthcare professional interactions — from initial selection and needs assessment through contracting, proof of performance, and payment — in one structured, auditable workflow. It automates HCP profiling and fair market value calculations, routes engagement requests through configurable approval workflows, and gives compliance teams full visibility into all HCP and HCO interactions.

Case IQ's HCP/HCO engagement management platform tracks interactions from nomination through proof of performance, with configurable workflows for each engagement type — speaker programs, advisory boards, consulting agreements, and more. Compliance teams can automate FMV calculations, set approval rules by engagement type or region, and monitor HCP/HCO transactions against aggregate spend thresholds and anti-kickback policy.

Case IQ helps life sciences companies manage grants, sponsorships, donations, and external funding through structured approval workflows with documented rationale — reducing regulatory and reputational risk. The platform centralizes the record of both the rationale and the approvals for external funding decisions, providing a vital audit trail for compliance risk detection and mitigation.

Case IQ's compliance monitoring platform ingests all historical CMS Sunshine Act Open Payments data to provide analytics on disclosed payments across the industry. Compliance teams use it to monitor aggregate spend, detect high-risk transactions, and support transparency reporting — with data drawn from existing enterprise systems and analyzed through algorithmic detection rules.

Yes. Case IQ supports conflict-of-interest management for life sciences compliance programs, collecting COI declarations, screening team members, and documenting approvals as part of engagement workflows. Compliance teams can configure disclosure requirements by engagement type, region, or business area — giving legal and compliance leadership a structured, auditable record of every COI determination.

Yes. Case IQ's life sciences compliance platform supports global programs in multiple languages with configurable workflows and AI playbooks adaptable by country, business area, and engagement type. Compliance teams can apply consistent approval rules across markets while allowing regional variation where local regulations or organizational requirements differ.

Yes. Case IQ's Approvals & Disclosures and HCP/HCO Engagements modules are purpose-built for life sciences compliance workflows — covering HCP engagement approvals, grant and sponsorship management, COI disclosures, and transparency reporting. Organizations that previously used standalone HCP engagement tools or manual processes have deployed Case IQ as a single, configurable compliance platform that adapts by engagement type and region.

Case IQ is used by pharmaceutical, biotech, biopharma, and medical device companies with formal compliance programs around HCP/HCO interactions and transfer-of-value risk. It is well-suited to emerging and mid-sized life sciences companies launching commercial activities or speakers programs — where compliance teams need one flexible platform instead of multiple specialized tools — and to global organizations that need multi-country, multi-language workflow support.